149 related articles for article (PubMed ID: 4609274)
1. An attempt to classify neuroleptic drugs on the basis of short-term clinical comparative studies.
Rodová A; Náhunek K; Svestka J
Act Nerv Super (Praha); 1974 Aug; 16(3):169-70. PubMed ID: 4609274
[No Abstract] [Full Text] [Related]
2. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
Elie R; Gagnon MA; Gauthier R; Jéquier JC
Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
[No Abstract] [Full Text] [Related]
3. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
Svestka J; Náhunek K; Rodová A; Cesková E
Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
[No Abstract] [Full Text] [Related]
4. [Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs].
Bukowczyk A; Wasik A; Horodnicki J
Psychiatr Pol; 1974; 8(2):143-8. PubMed ID: 4830321
[No Abstract] [Full Text] [Related]
5. [The depot neuroleptic agent fluspirilene (author's transl)].
Angst J; Frei M; Scharfetter Chr
Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):13-28. PubMed ID: 4602371
[No Abstract] [Full Text] [Related]
6. The purely neuroleptic effects and its relation to the "neuroleptic threshold".
Haase HJ
Acta Psychiatr Belg; 1978; 78(1):19-36. PubMed ID: 645405
[TBL] [Abstract][Full Text] [Related]
7. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
Ferrari P; Robotti E; Nardini M
Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407
[No Abstract] [Full Text] [Related]
8. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
Simpson GM; Varga V
Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
[No Abstract] [Full Text] [Related]
9. [Clinical comparison of methophenazine and perphenazine in schizophrenia. A controlled study. Effects on the photomyoclonic threshold].
Náhunek K; Svestka J; Misurec J
Act Nerv Super (Praha); 1967 Nov; 9(4):404-5. PubMed ID: 4889075
[No Abstract] [Full Text] [Related]
10. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
Angst J; Woggon B
Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
[TBL] [Abstract][Full Text] [Related]
11. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
Svestka J; Náhunek K
Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
[No Abstract] [Full Text] [Related]
12. Evaluation of loxapine succinate in chronic schizophrenia.
Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
[No Abstract] [Full Text] [Related]
13. The extrapyramidal neuroleptic syndrome: description and measurement.
Elie R; Gagnon MA; Lamontagne Y; Tetreault L
Curr Ther Res Clin Exp; 1973 Jul; 15(7):427-40. PubMed ID: 4198304
[No Abstract] [Full Text] [Related]
14. [Controlled studies with thiothixene and perphenazine in schizophrenic psychoses].
Hádlík J; Svestka J; Náhunek K; Rodová A
Act Nerv Super (Praha); 1970 Jan; 12(1):60-1. PubMed ID: 4907392
[No Abstract] [Full Text] [Related]
15. [Comparative double blind study between chlozapine and chlorpromazine in schizophrenia].
Ruíz Ruíz M
Arch Neurobiol (Madr); 1974 Mar; 37(2):169-80. PubMed ID: 4600866
[No Abstract] [Full Text] [Related]
16. Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.
McClelland HA
Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):401-3. PubMed ID: 9966
[No Abstract] [Full Text] [Related]
17. [Report on the clinical test of the long-term neuroleptic agent penfluridol].
Glatzel J
Med Welt; 1973 Dec; 24(51):2044-6. PubMed ID: 4204355
[No Abstract] [Full Text] [Related]
18. The pharmacist in the care of ambulatory mental health patients.
Ivey MF
Am J Hosp Pharm; 1973 Jul; 30(7):599-602. PubMed ID: 4715103
[No Abstract] [Full Text] [Related]
19. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
Huygens H; Vereecken JL; Tanghe A
Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
[No Abstract] [Full Text] [Related]
20. Butaperazine (Repoise).
Med Lett Drugs Ther; 1968 Nov; 10(22):89-90. PubMed ID: 4389275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
